144 related articles for article (PubMed ID: 36935093)
21. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study.
Almasoudi HH; Mashraqi MM; Alshamrani S; Alsalmi O; Alharthi AA; Gharib AF
J Biomol Struct Dyn; 2024; 42(1):11-21. PubMed ID: 37771142
[TBL] [Abstract][Full Text] [Related]
22. The discovery of subunit-selective GluN1/GluN2B NMDAR antagonist via pharmacophere-based virtual screening.
Tang J; Jin J; Huang Z; An F; Huang C; Jiang W
Exp Biol Med (Maywood); 2023 Dec; 248(24):2560-2577. PubMed ID: 38282535
[TBL] [Abstract][Full Text] [Related]
23. Visible-light promoted catalyst-free (VLCF) multi-component synthesis of spiro indolo-quinazolinone-pyrrolo[3,4-a]pyrrolizine hybrids: evaluation of
Iqbal S; Farhanaz ; Roohi ; Zaheer MR; Shankar K; Hussain MK; Zia Q; Rehman MT; AlAjmi MF; Gupta A
J Biomol Struct Dyn; 2024 Apr; 42(6):3145-3165. PubMed ID: 37227775
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
[TBL] [Abstract][Full Text] [Related]
25. Molecular modelling of SdiA protein by selected flavonoid and terpenes compounds to attenuate virulence in
Adeosun IJ; Baloyi I; Aljoundi AK; Salifu EY; Ibrahim MA; Cosa S
J Biomol Struct Dyn; 2023 Nov; 41(19):9938-9956. PubMed ID: 36416609
[No Abstract] [Full Text] [Related]
26. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
[TBL] [Abstract][Full Text] [Related]
27.
Akabli T; Toufik H; Lamchouri F
J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
[TBL] [Abstract][Full Text] [Related]
28. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
[TBL] [Abstract][Full Text] [Related]
29. Screening of indole derivatives as the potent anticancer agents on dihydrofolate reductase: pharmaco-informatics and molecular dynamics simulation.
Abdolmaleki B; Maddah M
J Biomol Struct Dyn; 2023 May; 41(8):3667-3679. PubMed ID: 35318890
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological profile and computational insights of new derivatives of benzo [B][1,4] diazepines as prospective anticancer agents for inhibiting the CDK-2 protein.
Dar PA; Bhat BA; Mir MA; Chaudhari SY; Shah WA
J Biomol Struct Dyn; 2024 Feb; ():1-16. PubMed ID: 38344942
[TBL] [Abstract][Full Text] [Related]
31. Probing some recent natural compounds from
Erdogan T; Oguz Erdogan F
J Biomol Struct Dyn; 2024 Jul; 42(10):5390-5401. PubMed ID: 37340683
[TBL] [Abstract][Full Text] [Related]
32. Computational approaches for evaluation of isobavachin as potential inhibitor against t877a and w741l mutations in prostate cancer.
Browne RB; Goswami N; Borah P; Roy JD
J Biomol Struct Dyn; 2023 Apr; 41(6):2398-2418. PubMed ID: 35118933
[TBL] [Abstract][Full Text] [Related]
33. Molecular docking and molecular dynamics simulations of a mutant
Anuar NFSK; Wahab RA; Huyop F; Amran SI; Hamid AAA; Halim KBA; Hood MHM
J Biomol Struct Dyn; 2021 Apr; 39(6):2079-2091. PubMed ID: 32174260
[TBL] [Abstract][Full Text] [Related]
34. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
Abbasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
[TBL] [Abstract][Full Text] [Related]
35. Citrus nutraceutical eriocitrin and its metabolites are partial agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a molecular docking and molecular dynamics study.
Gangadhariah M; Pardhi T; Ravilla J; Chandra S; Singh SA
J Biomol Struct Dyn; 2023; 41(21):11373-11393. PubMed ID: 36576222
[TBL] [Abstract][Full Text] [Related]
36. Structure-based design approach of potential BCL-2 inhibitors for cancer chemotherapy.
Krishna S; Kumar SB; Murthy TPK; Murahari M
Comput Biol Med; 2021 Jul; 134():104455. PubMed ID: 33962088
[TBL] [Abstract][Full Text] [Related]
37. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of binding and antagonism/downregulation of brilanestrant molecule in estrogen receptor-α via quantum mechanics/molecular mechanics, molecular dynamics and binding free energy calculations.
Chinnasamy K; Saravanan M; Poomani K
J Biomol Struct Dyn; 2020 Jan; 38(1):219-235. PubMed ID: 31038398
[TBL] [Abstract][Full Text] [Related]
39. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
Akash S; Aovi FI; Azad MAK; Kumer A; Chakma U; Islam MR; Mukerjee N; Rahman MM; Bayıl I; Rashid S; Sharma R
PLoS One; 2023; 18(10):e0283271. PubMed ID: 37824496
[TBL] [Abstract][Full Text] [Related]
40. Molecular dynamics simulation studies on influenza A virus H5N1 complexed with sialic acid and fluorinated sialic acid.
Jeyaram RA; Priyadarzini TRK; Anu Radha C; Siva Shanmugam NR; Ramakrishnan C; Gromiha MM; Veluraja K
J Biomol Struct Dyn; 2019 Nov; 37(18):4813-4824. PubMed ID: 30686127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
